Skip to main content
FinSpry Logo
FinSpry
HBIO logo
HBIO
(NASDAQ)
Harvard Bioscience, Inc.
$6.64-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Harvard Bioscience (HBIO) Stock Price & Financial Analysis

Harvard Bioscience Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$6.01 - $6.49
52-Week High$8.40
52-Week Low$0.38
Open$6.31
Volume10.60K
Average Volume (3M)29.18K
Market Cap26.81M
Shares Outstanding4.44M
Price to Sales (P/S)0.31
Price to Book (P/B)1.95
EV/EBITDA9.95
Revenue (TTM)86.55M
Net Income (TTM)-56.70M
Free Cash Flow (TTM)5.33M
EPS (TTM)$-12.79
Profit Margin-65.51%
Operating Margin-55.82%
Return on Equity (ROE)-412.84%
Debt to Equity3.22
50-Day MA$5.89
200-Day MA$3.72
52-Week Change1369.80%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Harvard Bioscience

What is the current stock price for HBIO?

As of the latest trading session, HBIO stock trades at $6.01. The 52-week range is $0.38–$8.40, with a day range of $6.01–$6.49.

What is the P/E ratio for HBIO?

The P/E ratio (Price-to-Earnings) for HBIO is shown in the Key Statistics section. This valuation metric helps compare Harvard Bioscience, Inc. to industry peers.

Does HBIO pay dividends?

Harvard Bioscience does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for HBIO?

Based on 1 analyst, the consensus for HBIO is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of HBIO?

Harvard Bioscience's market capitalization is $26.7M, classifying it as a micro-cap company..